[go: up one dir, main page]

BR0312444A - Acutumine and acutumine compounds, synthesis and use - Google Patents

Acutumine and acutumine compounds, synthesis and use

Info

Publication number
BR0312444A
BR0312444A BR0312444-4A BR0312444A BR0312444A BR 0312444 A BR0312444 A BR 0312444A BR 0312444 A BR0312444 A BR 0312444A BR 0312444 A BR0312444 A BR 0312444A
Authority
BR
Brazil
Prior art keywords
acutumine
compounds
synthesis
acutumin
alkoxy group
Prior art date
Application number
BR0312444-4A
Other languages
Portuguese (pt)
Inventor
Guo-Wei Qin
Xi-Can Tang
Pierre Lestage
Daniel Henri Caignard
Pierre Renard
Original Assignee
Shanghai Inst Materia Medica
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Inst Materia Medica, Servier Lab filed Critical Shanghai Inst Materia Medica
Publication of BR0312444A publication Critical patent/BR0312444A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/96Spiro-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)

Abstract

"ACUTUMINA E COMPOSTOS DE ACUTUMINA, SìNTESE E USO". A presente invenção refere-se a acutumina e compostos do mesmo e também a compostos de fórmula (I) em que R~ 1~ e R~ 2~ cada representam um átomo de hidrogênio ou juntos formam uma ligação adicional, R~ 3~ representa um átomo de hidrogênio ou um grupamento alcóxi, R~ 3~ representa um átomo de hidrogênio ou cloro, R~ 6~ representa um átomo de hidrogênio ou um grupamento alquila, alquilcarbonila ou amila, R~ 7~ e R~ 10~ cada representam um grupamento alcóxi, RIO representa um grupamento alcóxi, R~ 4~, R~ 8~, R~ 9~, R~ 11~, R~ 12~, R~ 13~ e R~ 14~ São conforme definido na descrição."ACUTUMIN AND ACUTUMIN COMPOUNDS, SYNTHESIS AND USE". The present invention relates to acutumin and compounds thereof and also to compounds of formula (I) wherein R 1 - and R 2 - each represent a hydrogen atom or together form an additional bond, R 3 - represents a hydrogen atom or an alkoxy group, R 3 represents a hydrogen or chlorine atom, R 6 represents a hydrogen atom or an alkyl, alkylcarbonyl or amyl group, R 7 and R 10 each represent an alkoxy group, R 10 represents an alkoxy group, R 4, R 8, R 9, R 11, R 12, R 13 and R 14 are as defined in the description.

BR0312444-4A 2002-06-25 2003-06-16 Acutumine and acutumine compounds, synthesis and use BR0312444A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNA021214794A CN1465566A (en) 2002-06-25 2002-06-25 Sinomenine and its compound, synthesis and use
PCT/IB2003/002600 WO2004000815A1 (en) 2002-06-25 2003-06-16 Acutumine and acutumine compounds, synthesis and use

Publications (1)

Publication Number Publication Date
BR0312444A true BR0312444A (en) 2005-05-10

Family

ID=29742994

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0312444-4A BR0312444A (en) 2002-06-25 2003-06-16 Acutumine and acutumine compounds, synthesis and use

Country Status (19)

Country Link
US (1) US20060167076A1 (en)
EP (1) EP1608625A1 (en)
JP (1) JP2006501174A (en)
KR (1) KR100677018B1 (en)
CN (2) CN1465566A (en)
AR (1) AR040462A1 (en)
AU (1) AU2003242278A1 (en)
BR (1) BR0312444A (en)
CA (1) CA2491214A1 (en)
EA (1) EA007229B1 (en)
GE (1) GEP20074178B (en)
MA (1) MA27264A1 (en)
MX (1) MXPA05000076A (en)
NO (1) NO20050214L (en)
NZ (1) NZ537405A (en)
PL (1) PL374039A1 (en)
UA (1) UA80555C2 (en)
WO (1) WO2004000815A1 (en)
ZA (1) ZA200410280B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2773590C (en) * 2009-09-09 2017-09-05 Keiji Adachi 8-oxodihydropurine derivative
AU2014101153A4 (en) * 2014-01-03 2014-10-23 Macau University Of Science And Technology A Group of Alkaloids, the Novel Autophagic Enhancers for Treatment of Cancers and Neurodegenerative Conditions Thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0154756B2 (en) * 1984-02-29 1996-10-23 Covex (S.A.) Citrate of vinpocetine, and process for its preparation
CN1052225A (en) * 1990-02-07 1991-06-12 福建省仙游电机厂 A kind of automobile current generator of big specific power and manufacture method thereof
CN1101812C (en) * 1997-12-19 2003-02-19 中国科学院上海药物研究所 Acorus calamus extracts in Acorus gramineus and their use

Also Published As

Publication number Publication date
CN1675183A (en) 2005-09-28
US20060167076A1 (en) 2006-07-27
CN1465566A (en) 2004-01-07
CN1303069C (en) 2007-03-07
JP2006501174A (en) 2006-01-12
GEP20074178B (en) 2007-08-10
EA200500081A1 (en) 2005-06-30
KR20050058999A (en) 2005-06-17
EP1608625A1 (en) 2005-12-28
NO20050214L (en) 2005-01-13
AR040462A1 (en) 2005-04-06
UA80555C2 (en) 2007-10-10
CA2491214A1 (en) 2003-12-31
MXPA05000076A (en) 2005-04-08
NZ537405A (en) 2006-03-31
PL374039A1 (en) 2005-09-19
AU2003242278A1 (en) 2004-01-06
MA27264A1 (en) 2005-03-01
KR100677018B1 (en) 2007-01-31
ZA200410280B (en) 2006-07-26
HK1077823A1 (en) 2006-02-24
WO2004000815A1 (en) 2003-12-31
EA007229B1 (en) 2006-08-25

Similar Documents

Publication Publication Date Title
ATE469892T1 (en) SUBSTITUTED 1H-DIHYDROPYRAZOLES, THEIR PREPARATION AND USE
TR200102338T2 (en) Cyclic substituted linked pyrolocarbazoles and isoindolones.
DE60208355D1 (en) 2-AMINO-PROPANOL DERIVATIVES
BR0308261A (en) Extractive Methods for Sucralose Purification
BRPI0411528A (en) use of isomalt as prebiotic
EA200501333A1 (en) 5,7-DIAMINOPYRAZOLO [4,3-d] Pyrimidines, useful in the treatment of hypertension
CY1109854T1 (en) AZADICYLIC PRODUCTS (3.1.0) EXCELLENT USEFUL AS D3 DOPAMIN RECEPTOR REGULATORS
MY143249A (en) 4-substituted pyrrolidin-2-ones and their use
BRPI0518758A2 (en) acetamide compounds as fungicides
DK1474406T3 (en) Disubstituted thiazolylcarboxanilides as well as their use as microbicides
ATE334654T1 (en) COMPOSITIONS PROTECTIVE FROM UV RAYS
MXPA02011370A (en) Substituted iminoazines.
BR0308211A (en) Coumarins Useful as Biomarkers
WO2004069793A3 (en) Novel 2-substituted cyclic amines as calcium sensing receptor modulators
AR034735A1 (en) SYNTHESIS AND INTERMEDIARIES
ATE291024T1 (en) NEW 4-AMINOFUROPYRIMIDINES AND THEIR USE
BR0211826A (en) Tricyclic imidazopyridines
DE602004031410D1 (en) INDIVIDUAL DERIVATIVES AS PHARMACEUTICALS
NO20040388L (en) Process for the preparation of beraprost and its salts, as well as compounds which are intermediates in the process
BR0211903A (en) Isoxazolopyridinones
MXPA06000038A (en) 2-substituted pyrimidines.
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
BR0312444A (en) Acutumine and acutumine compounds, synthesis and use
DE60222244D1 (en) PROCESS FOR PREPARING INTERCONNECTIONS IN THE MANUFACTURE OF DISCODERMOLID AND DISCODERMOLID ANALOGUE
DK1644385T3 (en) Silicon compounds and their use

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A. E 7A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2064 DE 27/07/2010.